RI

Robert Ingui

Chief Financial & Commercial Services Officer at Phebra Pty Ltd

Robert Ingui has extensive work experience spanning over several companies. Robert is currently serving as the Chief Financial & Commercial Services Officer at Phebra Pty Ltd since March 2022. Prior to this, they worked at Mundipharma Australia for over two decades as the Finance and Operations Director, where they had full operational and general management responsibilities for both the Australian and New Zealand businesses. Robert was also in charge of finance functions, including P&L responsibility, corporate taxation, treasury, and budget preparations. Before joining Mundipharma, Robert held roles as Financial Controller & Company Secretary at Medicine Quantale Limited, Australian Topmaking Services Limited, and Gowing Bros Limited. Robert began their career at KPMG as an Auditor.

Robert Ingui holds a Bachelor's Degree in Accounting from the University of Technology Sydney. Robert also completed their High School Certificate at CBHS Lewisham. In addition, they obtained a Graduate Certificate in Business, Supply Chain and Logistics Management from Victoria University. Robert has further certifications including Fellow (FCA) from the Institute of Chartered Accountants in Australia, Fellow (FCIS, FGIA) from the Governance Institute of Australia, and they are also a Justice of the Peace, certified by the NSW Government Justice/Attorney Generals.

Location

Sydney, Australia

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Phebra Pty Ltd

Phebra is one of Australia’s largest privately-owned pharmaceutical groups, with a manufacturing facility in Sydney which develops, produces and markets critical medicines in Australia and across the world. Since 1993, Phebra has built a reputation for innovation, product development and manufacture of over 65 medicines in critical therapeutic disease areas such as cystic fibrosis, antidotes, diagnostics, oncology and pain. Being dynamic and innovative, Phebra collaborates with healthcare providers to research, develop and produce critical medicines to meet unmet needs.


Employees

51-200

Links